Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity - PubMed (original) (raw)

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

Harmeet Malhi et al. Gut. 2007 Aug.

Abstract

Background: Elevated circulating free fatty acids (FFA) contribute to the development of hepatic steatosis and promote hepatocyte apoptosis by incompletely defined mechanisms. Although the death ligand TRAIL has been implicated in a variety of pathological liver diseases, the role of TRAIL in mediating apoptosis of FFA induced steatotic hepatocytes is unknown.

Aim: We examined TRAIL cytotoxicity in an in vitro model of hepatocyte steatosis induced by FFA.

Methods: Hepatocytes (Huh 7 cells, HepG2 cells, and primary rat hepatocytes) were rendered steatotic by incubation with oleic acid. Apoptosis was assessed morphologically and biochemically by caspase activity. TRAIL receptor regulation was examined using immunoblot analysis and siRNA for targeted knockdown. c-jun N-terminal kinase (JNK) inhibition was attained with SP600125.

Results: Oleic acid sensitised the cells to TRAIL but not TNF-alpha cytotoxicity. FFA sensitisation to TRAIL occurred at much lower concentrations than required for FFA mediated sensitisation to Fas, or FFA induced lipoapoptosis. Oleic acid treatment led to upregulation of the cognate TRAIL receptor death receptor 5 (DR5) but not death receptor 4 (DR4). The upregulation of DR5 was JNK dependent. siRNA targeted knockdown of either DR5 or DR4 demonstrated that DR5 was responsible for FFA sensitisation to TRAIL killing. DR5 expression was enhanced in steatotic human liver samples.

Conclusion: Our results suggest that FFA induced hepatocyte steatosis sensitises to TRAIL by a DR5 mediated JNK dependent mechanism.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Figures

Similar articles

Cited by

References

    1. Chou A H, Tsai H F, Wu Y Y.et al Hepatitis C virus core protein modulates TRAIL‐mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J Immunol 20051742160–2166. - PubMed
    1. Feldstein A E, Canbay A, Angulo P.et al Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003125437–443. - PubMed
    1. Ribeiro P S, Cortez‐Pinto H, Sola S.et al Hepatocyte apoptosis, expression of death receptors, and activation of NF‐kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 2004991708–1717. - PubMed
    1. Wu J, Danielsson A, Zern M A. Toxicity of hepatotoxins: new insights into mechanisms and therapy. Expert Opin Invest Drugs 19998585–607. - PubMed
    1. Sanyal A J. Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2005246–53. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources